Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ABBV-184 |
Synonyms | |
Therapy Description |
ABBV-184 is a bispecific molecule that targets survivin and CD3, which crosslinks survivin-expressing tumor cells and lymphocytes, potentially leads to T-cell mediated killing of tumor cells (PMID: 37294945). |